Delivery Order SPE2DR25D2014-SPE2DR26FA0E8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) with a ceiling value of $18,785.66. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on November 5, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) with a ceiling value of $1,554.35. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) with a ceiling value of $24,321. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by December 12, 2025, and will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) at a ceiling value of $13,135.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract has an ultimate completion date of December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) with a ceiling value of $3,567.44. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The order is scheduled for completion by September 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets in a 90-count package, with a ceiling value of $1,503.73. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract calls for performance completion by December 4, 2025, with fulfillment to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a 90-count quantity, with a ceiling value of $1,867.39. This firm fixed-price delivery order has an ultimate completion date of October 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 13, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets in a 90-day supply at a ceiling value of $8,041.08. This firm fixed-price delivery order, with an ultimate completion date of December 15, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive, competitively awarded contract with no set-aside designation, leveraging...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) with a ceiling value of $3,300.21. This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Losartan-HCTZ 50-12.5 mg tablets (90-count supply) with a contract value of $11,284.61. This competitively awarded, firm fixed-price delivery order was issued on October 15, 2025, with completion targeted for October 16, 2025. The award carries no set-aside designation, reflecting open competition among qualified vendors. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0E8Delivery Order
This delivery order, awarded December 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides Losartan-HCTZ 50-12.5 mg tablets in a 90-count supply with a ceiling value of $12,142.17. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, with completion targeted for December 19, 2025. This order represents a pharmaceutical supply need for what is a commonly prescribed antihypertensive medication used across military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which extends through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen provides comprehensive pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The parent IDC serves as a global pharmaceutical support vehicle enabling flexible fulfillment of diverse medication and medical commodity requirements across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 12/17/25 |